Rchr
J-GLOBAL ID:202001011630752548   Update date: Jun. 16, 2025

Matsuoka Katsuyoshi

マツオカ カツヨシ | Matsuoka Katsuyoshi
Affiliation and department:
Job title: Professor
Research theme for competitive and other funds  (6):
  • 2021 - 2024 腸管と脾臓のクロストーク~全身性疾患としての炎症性腸疾患~
  • 2017 - 2022 Role of oral-care in inflammatory bowel disease patients in remission: an oral and intestinal bacteria-based study
  • 2017 - 2019 Development of hybrid intestine system and its applications
  • 2013 - 2016 Identification of the pathogenic virus of ulcerative colitis using the next-generation sequencing techonology
  • 2010 - 2012 Bactericidal function of neutrophils in Crohn`s disease
Show all
Papers (31):
  • Naganuma M, Shiga H, Shimoda M, Matsuura M, Takenaka K, Fujii T, Yamamoto S, Matsubayashi M, Kobayashi T, Aoyama N, et al. First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study. Journal of Gastroenterology. 2025. 60. 4. 430-441
  • Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, Hamada K, Kitamoto H, Kuwada T, Uza N, et al. Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study. Journal of Gastroneterology. 2024. 60. 86-95
  • Danese S, Dignass A, Matsuoka K, Ferrante M, Long M, Redondo I, Moses R, Maier S, Hunter Gibble T, Morris N, et al. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme. journal of crohn's and colitis. 2024. 18. 1845-1856
  • Feagan BG, Matsuoka K, Rogler G, Laharie D, Vermeire S, Danese S, Loftus EV Jr, Beales I, Schreiber S, Kim HJ, et al. Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Alimentary pharmacology & therapeutics. 2024. 60. 5. 563-584
  • Matsuoka K, Inoue T, Tsuchiya H, Nagano K, Iwahori T. Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study. Intestinal Research. 2024. 22. 3. 319-335
more...
Work history (1):
  • 2018/04 - 現在 Toho University Faculty of Medicine School of Medicine (Sakura) Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page